3
Participants
Start Date
February 28, 2002
Primary Completion Date
August 31, 2011
Study Completion Date
August 31, 2011
therapeutic autologous lymphocytes
Cycles of escalating cell dose infusions up to the target cell dose of 10(8)
gene expression analysis
At the time of excess pathology samples documenting response/relapse
laboratory biomarker analysis
CSF generated at the time of each T-cell dose
National Cancer Institute (NCI)
NIH
City of Hope Medical Center
OTHER